Source: Annual Congress 2002 - Rhinitis
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Swierczynska, E. Nizankowska, P. Strẻk, A. Szczeklik (Krakow, Poland). Alterations in eicosanoid metabolism in distinct types of rhinitis. Eur Respir J 2002; 20: Suppl. 38, 1437

Member's Comments

No comment yet.

Related content which might interest you: Role of beta2-agonists in the formation of carbohydrate metabolism disorders in the patients with asthma Source: Eur Respir J 2005; 26: Suppl. 49, 683s Year: 2005 Lipid mediator profiles differ between lung compartments in asthmatic and healthy humans Source: Eur Respir J 2014; 43: 453-463 Year: 2013 Features of adipokine regulation at young patients with bronchial asthma with different phenotypes of obesity Source: International Congress 2019 – Understanding the mechanisms underlying airway diseases Year: 2019 Changes in human nasal mucosal innervation in environmentally triggered hyperreflectoric rhinitis Source: Eur Respir J 2003; 22: Suppl. 45, 119s Year: 2003 Hypersensitivity to aspirin: common eicosanoid alterations in urticaria and asthma Source: Eur Respir J 2004; 24: Suppl. 48, 444s Year: 2004 The phenotypical peculiarities of atopic bronchial asthma in children with different genotypes of ACE enzymes Source: Annual Congress 2008 - Risk factors for childhood asthma and allergy Year: 2008 Correlations between cellular and soluble markers in the treatment with new polipeptide RUZAM in patients with allergic rhinitis Source: Eur Respir J 2005; 26: Suppl. 49, 368s Year: 2005 The carnitine pathway is dysregulated in asthma in an oral corticosteroid-independent mechanism Source: Virtual Congress 2021 – Deep phenotyping of obstructive diseases for precision medicine Year: 2021 A decreased expression of leptin receptor may contribute to the pathogenesis of the allergic rhinitis Source: Annual Congress 2010 - Asthma: clinical aspects and treatment Year: 2010 Novel roles of oligodeoxynucleotides in regulating allergic airway eosinophilia Source: Eur Respir J 2004; 24: Suppl. 48, 354s Year: 2004 Erdosteine affects eicosanoid production in asthma and COPD Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of asthma Year: 2008 Dysregulation of lipid mediators in clinically stable bronchiectasis Source: International Congress 2018 – Mechanisms of respiratory infection Year: 2018 Peculiarities of calcium-phosphorus metabolism and lung function in patients with bronchial asthma Source: Eur Respir J 2003; 22: Suppl. 45, 420s Year: 2003 Mechanisms and physiology of asthma Source: ERS Satellites 2021 Year: 2021 Allergen immunotherapy modulates pro- and antioxidant status patients with bronchial asthma Source: International Congress 2017 – Asthma and allergy: from the bench to the bedside Year: 2017 The rate of carbohydrate metabolism disorders in the patients with bronchial asthma Source: Annual Congress 2009 - Asthma and comorbid conditions Year: 2009 Differences between intermediate phenotypes underlying asthma and rhinitis Source: Annual Congress 2008 - Epidemiology of asthma and allergy Year: 2008 The leukotriene E4 excretion following nasal aspirin challenges in patients with rhinitis and asthma assessed by two distinct methods Source: Annual Congress 2007 - Noninvasive evaluation of airway diseases Year: 2007 Different inhaled corticosteroids altered lung microbiome and regulating the expression of PAF receptor as well as the phagocytosis function of macrophage Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations Year: 2019 Dual pathways of asthmatic inflammation and clinical implications Source: Annual Congress 2003 - New insights in airway inflammation Year: 2003